Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

ClinicalTrials.gov ID: NCT00567424

Public ClinicalTrials.gov record NCT00567424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Evaluation of Drug Interactions, Safety, Tolerability and Efficacy of GW273225 Add-on Treatment of Partial Seizures, Whether or Not Secondarily Generalized

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin

Study identification

NCT ID
NCT00567424
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Apr 4, 2013

2006 – 2008

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
GSK Clinical Trials Call Center Phoenix Arizona 85054 —
GSK Clinical Trials Call Center Sun City Arizona 85351 —
GSK Clinical Trials Call Center Little Rock Arkansas 72205 —
GSK Clinical Trials Call Center San Jose California 95128 —
GSK Clinical Trials Call Center Santa Monica California 90404 —
GSK Clinical Trials Call Center Jacksonville Florida 32209 —
GSK Clinical Trials Call Center Tallahassee Florida 32308 —
GSK Clinical Trials Call Center Tampa Florida 33613 —
GSK Clinical Trials Call Center Chicago Illinois 60612 —
GSK Clinical Trials Call Center Springfield Illinois 62704 —
GSK Clinical Trials Call Center Iowa City Iowa 52242 —
GSK Clinical Trials Call Center Wichita Kansas 67214 —
GSK Clinical Trials Call Center Baltimore Maryland 21287 —
GSK Clinical Trials Call Center Boston Massachusetts 02215 —
GSK Clinical Trials Call Center Rochester Minnesota 55905 —
GSK Clinical Trials Call Center Saint Cloud Minnesota 56303 —
GSK Clinical Trials Call Center Springfield Missouri 65804 —
GSK Clinical Trials Call Center St Louis Missouri 63310 —
GSK Clinical Trials Call Center Amherst New York 14226 —
GSK Clinical Trials Call Center Durham North Carolina 27560 —
GSK Clinical Trials Call Center Cleveland Ohio 44195 —
GSK Clinical Trials Call Center Toledo Ohio 43614 —
GSK Clinical Trials Call Center Medford Oregon 97504 —
GSK Clinical Trials Call Center Portland Oregon 97225 —
GSK Clinical Trials Call Center Portland Oregon 97239-3098 —
GSK Clinical Trials Call Center Dallas Texas 75230 —
GSK Clinical Trials Call Center Burlington Vermont 05401 —
GSK Clinical Trials Call Center Richmond Virginia 23219 —
GSK Clinical Trials Call Center Roanoke Virginia 24018 —
GSK Clinical Trials Call Center Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00567424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2013 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00567424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →